drugset / Trial / NCT00768820

The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome

NCT00768820

Phase 4 Recruiting 400 enrolled The Chaim Sheba Medical Center
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to investigate the Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors

Timeline

Start
2001-05
Primary completion
2027-08
Completion
2027-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylphenidate Small molecule
Background Fluoxetine Small molecule
Background Risperidone Other / unclassified